JPMorgan Chase & Co. Downgrades ICON Public (NASDAQ:ICLR) to Neutral
ICON Public (NASDAQ:ICLR – Get Free Report) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research note issued to investors on Tuesday, MarketBeat.com reports. They presently have a $150.00 price objective on the medical research company’s stock, down from their prior price objective of […]
ICON Public (NASDAQ:ICLR – Get Free Report) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research note issued to investors on Tuesday, MarketBeat.com reports. They presently have a $150.00 price objective on the medical research company’s stock, down from their prior price objective of […]
